TSE:CMED - CanniMed Therapeutics Stock Price, Price Target & More

C$32.52 -1.02 (-3.04 %)

(As of 04/19/2018 11:55 AM ET)

Previous CloseC$33.54

Today's RangeC$32.50 - C$33.71

52-Week RangeC$7.32 - C$46.00

Volume13,168 shs

Average Volume424,047 shs

Market CapitalizationC$954.12 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

About CanniMed Therapeutics (TSE:CMED)

CanniMed Therapeutics Inc. operates as a plant biopharmaceutical company that specializes in medical cannabis. The company cultivates and sells pharmaceutical-grade cannabis products in dried herbal and oil forms for Canadian patients. It also offers herbal cannabis and cannabis oil; and vaporizers, consumable vaporizer accessories, and herb mills. In addition, the company offers a plant biotechnology research and product development program that focuses on the production of plant-based materials for pharmaceutical, agricultural, and environmental applications. CanniMed Therapeutics Inc. was founded in 1988 and is based in Saskatoon, Canada.

Receive CMED News and Ratings via Email

Sign-up to receive the latest news and ratings for CMED and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A

Sub-IndustryCannabis

SectorN/A

SymbolTSE:CMED

CUSIPN/A

Webwww.cannimedtherapeutics.com

Phone+1-306-9751207

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / CashN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net Margins-28.43%

Return on Equity-5.96%

Return on Assets-4.95%

Miscellaneous

EmployeesN/A

Outstanding Shares24,757,000

How to Become a New Pot Stock Millionaire

CanniMed Therapeutics (TSE:CMED) Frequently Asked Questions

What is CanniMed Therapeutics' stock symbol?

CanniMed Therapeutics trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CMED."

Who are some of CanniMed Therapeutics' key competitors?

Some companies that are related to CanniMed Therapeutics include EnerCare (ECI), Westshore Terminals Investment (WTE.UN), Enghouse Systems (ENGH), Russel Metals (RUS), Superior Plus (SPB), Innergex Renewable Energy (INE), New Gold (NGD), Richelieu Hardware (RCH), NovaGold Resources (NG), Shawcor (SCL), Boralex (BLX), Hudson's Bay (HBC), Milestone Apartments Real Estate Invt Tr (MST.UN), Pretium Resources (PVG), Dream Office Real Estate Investment Trust (D.UN), Interfor (IFP), ATS Automation Tooling Systems (ATA) and First National Financial (FN).

Who are CanniMed Therapeutics' key executives?

CanniMed Therapeutics' management team includes the folowing people:

Donald R. Ching, Independent Chairman of the Board (Age 74)
Brent Zettl, President, Chief Executive Officer, Director (Age 54)
John L. Knowles, Chief Financial Officer, Corporate Secretary, Director (Age 61)
Gulwant Bajwa, Vice President - Business Development and Regulatory Affairs (Age 54)
Larry Holbrook, Chief Research Officer (Age 69)
Douglas W. Banzet, Independent Director (Age 66)
Rob Duguid, Independent Director (Age 52)
Marianne Greer Ph.D., Independent Director (Age 63)
Richard Hoyt, Independent Director (Age 63)
Dwayne Lawrence Lashyn, Independent Director (Age 52)

Has CanniMed Therapeutics been receiving favorable news coverage?

Media stories about CMED stock have trended somewhat negative recently, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. CanniMed Therapeutics earned a media sentiment score of -0.03 on Accern's scale. They also gave news articles about the company an impact score of 46.31 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

How do I buy shares of CanniMed Therapeutics?

Shares of CMED and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is CanniMed Therapeutics' stock price today?

One share of CMED stock can currently be purchased for approximately C$32.52.

How big of a company is CanniMed Therapeutics?

CanniMed Therapeutics has a market capitalization of C$954.12 million.

How can I contact CanniMed Therapeutics?

CanniMed Therapeutics' mailing address is 1 Plant Technology Road, Box 19A, RR #5, SASKATOON, SK S7K 3J8, Canada. The company can be reached via phone at +1-306-9751207.

MarketBeat Community Rating for CanniMed Therapeutics (CMED)

Community Ranking:		3.2 out of 5 ( )
Outperform Votes:		99 (Vote Outperform)
Underperform Votes:		57 (Vote Underperform)
Total Votes:		156

MarketBeat's community ratings are surveys of what our community members think about CanniMed Therapeutics and other stocks. Vote "Outperform" if you believe CMED will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CMED will underperform the S&P 500 over the long term. You may vote once every thirty days.

CanniMed Therapeutics (TSE:CMED) Analyst Ratings History

Date	Brokerage	Action	Rating	Price Target	Details

(Data available from 4/19/2016 forward)

CanniMed Therapeutics (TSE:CMED) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

CanniMed Therapeutics (TSE CMED) Insider Trading and Institutional Ownership History

Insider Trading History for CanniMed Therapeutics (TSE:CMED)

CanniMed Therapeutics (TSE CMED) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
2/8/2018	Allan Mclay Fowler	Insider	Sell	31,777	C$31.81	C$1,010,826.37
1/31/2018	Larry Holbrook	Insider	Sell	10,000	C$34.89	C$348,900.00
10/3/2017	Larry Holbrook	Insider	Sell	5,000	C$10.25	C$51,250.00
9/18/2017	Larry Holbrook	Insider	Sell	1,000	C$9.41	C$9,410.00
7/31/2017	Larry Holbrook	Insider	Sell	100	C$10.05	C$1,005.00
7/13/2017	Saskworks Venture Fund Inc.	Insider	Buy	126,500	C$8.35	C$1,056,275.00
7/7/2017	Saskworks Venture Fund Inc.	Insider	Buy	21,500	C$8.14	C$175,010.00
6/28/2017	Brenton Harold Zettl	Director	Buy	7,300	C$7.99	C$58,327.00
6/27/2017	Brenton Harold Zettl	Director	Buy	7,300	C$7.99	C$58,327.00
6/15/2017	Brenton Harold Zettl	Director	Buy	50,000	C$7.91	C$395,500.00

(Data available from 1/1/2013 forward)

CanniMed Therapeutics (TSE CMED) News Headlines

Source:

Date	Headline
	Who Are The Top Investors In CanniMed Therapeutics Inc (TSE:CMED)? finance.yahoo.com - April 18 at 5:43 PM
	Why CanniMed Therapeutics Inc’s (TSE:CMED) ROE Of 3.37% Does Not Tell The Whole Story finance.yahoo.com - April 10 at 5:28 PM
	UPDATE 1-CanniMed CEO resigns, Aurora Therapeutics exec tapped interim CEO www.reuters.com - April 2 at 8:43 AM
	CanniMed CEO resigns, Aurora Therapeutics exec tapped interim CEO finance.yahoo.com - April 2 at 8:43 AM
	Is Aphria Inc. Still Harbouring U.S. Expansion Ambitions? www.fool.ca - March 26 at 5:14 PM
	Today’s Research Reports on Knight Therapeutics, Crescita Therapeutics, CanniMed Therapeutics and Cipher Pharmaceuticals finance.yahoo.com - March 22 at 8:30 AM
	CanniMed Therapeutics Inc. Announces First Quarter Results finance.yahoo.com - March 19 at 8:25 AM
	Changes to CanniMed Therapeutics Board Following Share Take ... - Business Wire (press release) www.businesswire.com - March 17 at 8:30 AM
	Is CanniMed Therapeutics Inc’s (TSE:CMED) Balance Sheet A Threat To Its Future? finance.yahoo.com - March 17 at 8:30 AM
	Pot producer Aurora wins shareholder support for CanniMed purchase - Reuters www.reuters.com - March 10 at 8:25 AM
	Pot producer Aurora wins shareholder support for CanniMed purchase finance.yahoo.com - March 9 at 6:47 PM
	Aurora Cannabis Announces Success in Bid for CanniMed Therapeutics Through the Take-Up of Shares finance.yahoo.com - March 9 at 6:47 PM
	Aurora Cannabis Shareholders Give the Company the Okay to Acquire CanniMed Therapeutics www.baystreet.ca - March 8 at 6:38 PM
	Aurora Cannabis Announces Receipt of Final Regulatory Approval for CanniMed Therapeutics Acquisition and its Intention to Take-Up as soon as Minimum Tender Condition is Met finance.yahoo.com - February 28 at 6:02 PM
	Pot producer Aurora gets final regulatory nod for CanniMed purchase finance.yahoo.com - February 28 at 6:02 PM
	CanniMed Medical Cannabis Topical Cream Provides Fast-Acting Relief to Patients in Need - Business Wire (press release) www.businesswire.com - February 28 at 8:20 AM
	CanniMed Medical Cannabis Topical Cream Provides Fast-Acting Relief to Patients in Need finance.yahoo.com - February 28 at 8:20 AM
	UPDATE--CTT Pharmaceutical Holdings, Inc., (CTTH) Announces Canadian Patent for Orally Administrable Nanonized ... - Nasdaq www.nasdaq.com - February 22 at 8:24 AM
	Allan Mclay Fowler Sells 31,777 Shares of CanniMed Therapeutics Inc (CMED) Stock www.americanbankingnews.com - February 12 at 9:16 PM
	Marijuana Stocks: A Performance Review and a Look Ahead www.fool.ca - February 12 at 9:51 AM
	Aurora Cannabis Inc. vs. Canopy Growth Corp.: Which Heavyweight Cannabis Stock Is the Best Bet Going Forward? www.fool.ca - February 3 at 9:41 AM
	Larry Holbrook Sells 10,000 Shares of CanniMed Therapeutics Inc (CMED) Stock www.americanbankingnews.com - February 1 at 6:30 PM
	What Scotts Miracle-Gro Said about Its Cannabis-Focused Business finance.yahoo.com - January 31 at 9:56 AM
	CanniMed Therapeutics Inc. Announces 2017 Year End Financials Release Date finance.yahoo.com - January 27 at 9:40 AM
	Aurora Cannabis Inc. vs. CanniMed Therapeutics Inc.: I’m Not Surprised www.fool.ca - January 25 at 3:45 PM
	Canada's Aurora Cannabis to buy CanniMed for C$1.1 billion www.reuters.com - January 25 at 3:45 PM
	PRESS DIGEST- Canada-Jan 25 finance.yahoo.com - January 25 at 9:46 AM
	CanniMed Therapeutics Announces Continued Discussions with Aurora - Business Wire (press release) www.businesswire.com - January 24 at 8:08 AM
	PRESS DIGEST- Canada - Jan 24 finance.yahoo.com - January 24 at 8:08 AM
	PRESS DIGEST- Canada-Jan 23 finance.yahoo.com - January 23 at 5:24 PM
	CanniMed Therapeutics Announces Continued Discussions with Aurora finance.yahoo.com - January 23 at 5:24 PM
	CanniMed Therapeutics Announces Continuation of Discussions with Aurora finance.yahoo.com - January 22 at 3:56 PM
	CANADA STOCKS-TSX retreats as railroad and materials shares weigh finance.yahoo.com - January 22 at 3:56 PM
	Canadian cannabis firm Aurora in talks to buy both CanniMed and Newstrike: sources www.reuters.com - January 19 at 6:28 PM
	CanniMed Topical Cream – An Innovative New Way to Help Patients - Business Wire (press release) www.businesswire.com - January 18 at 9:17 AM
	CanniMed Therapeutics Reminds Shareholders to Vote the GREEN Proxy FOR the Acquisition of Newstrike Resources - Business Wire (press release) www.businesswire.com - January 18 at 9:17 AM
	Up Cannabis-parent Newstrike's shareholders approve sale to CanniMed finance.yahoo.com - January 17 at 5:58 PM
	CanniMed Therapeutics Inc. Announces Director Resignation finance.yahoo.com - January 17 at 8:44 AM
	CanniMed Topical Cream – An Innovative New Way to Help Patients finance.yahoo.com - January 17 at 8:44 AM
	CanniMed Therapeutics Reminds Shareholders to Vote the GREEN Proxy FOR the Acquisition of Newstrike Resources finance.yahoo.com - January 17 at 8:44 AM
	Shareholders of Aurora Cannabis Inc. Will Get Some Important Answers This Week www.fool.ca - January 15 at 5:46 PM
	CanniMed Therapeutics Inc. Launches $725 Million Lawsuit Alleging Multiple Claims of Wrongdoing Related to Aurora Hostile Bid www.businesswire.com - January 13 at 9:00 AM
	Leading Independent Proxy Advisor ISS Recommends CanniMed Shareholders Vote “FOR” the Newstrike Acquisition finance.yahoo.com - January 11 at 5:55 PM
	CanniMed Therapeutics Inc. and Up Cannabis Inc. (Wholly-Owned Licensed Producer of Newstrike Resources Ltd.) Applaud the Province of Saskatchewan on Legalization Framework finance.yahoo.com - January 8 at 5:57 PM
	CanniMed Therapeutics Inc. and Up Cannabis Inc. (Wholly-Owned Licensed Producer of Newstrike Resources Ltd ... - Business Wire (press release) www.businesswire.com - January 3 at 8:12 AM
	Canadian regulators ask CanniMed to abandon rights plan against Aurora bid - Reuters www.reuters.com - December 28 at 5:13 PM
	Aurora Cannabis opposes CanniMed's bid for Newstrike Resources - Reuters www.reuters.com - December 19 at 5:46 PM
	CanniMed Therapeutics Inc.'s Latest Attempt to Stifle the Aurora Cannabis Inc. Takeover Bid - The Motley Fool Canada www.fool.ca - December 19 at 5:46 PM
	Ontario regulator to hear Aurora, CanniMed cases on Dec. 20 finance.yahoo.com - December 13 at 5:59 PM
	Aurora Cannabis wins rights for licensing talks with CannaRoyalty finance.yahoo.com - December 13 at 9:14 AM

CanniMed Therapeutics (TSE:CMED) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Financials are not available for this stock.

CanniMed Therapeutics (TSE CMED) Stock Chart for Thursday, April, 19, 2018

Loading chart…

This page was last updated on 4/19/2018 by MarketBeat.com Staff